IMPACT OF MYOCARDIAL VIABILITY AND CORONA RY REVASCULARIZATION ON CLINICAL OUTCOME AND PROGNOSIS - AN OBSERVATIONAL STUDY IN 161 PATIENTS WITH CORONARY-ARTERY DISEASE
J. Vomdahl et al., IMPACT OF MYOCARDIAL VIABILITY AND CORONA RY REVASCULARIZATION ON CLINICAL OUTCOME AND PROGNOSIS - AN OBSERVATIONAL STUDY IN 161 PATIENTS WITH CORONARY-ARTERY DISEASE, Zeitschrift fur Kardiologie, 85(11), 1996, pp. 868-881
One hundred and sixty-one consecutive patients (144 male, 57 +/- 9 yea
rs) with stable coronary artery disease underwent nuclear imaging for
assessment of myocardial viability using Tc-99m sestamibi single-photo
n emission computed tomography (SPECT) and F-18 fluoro-deoxy-glucose (
FDG) positron emission tomography (PET). 88 % had a history of chronic
myocardial infarction and all had angiographically proven regional wa
ll motion (RWM) abnormalities in the distribution territory of a steno
sed or occluded coronary artery. Patients were followed for 29 +/- 6 (
22-44) months with 84/161 patients (52 %) receiving elective revascula
rization by either bypass surgery or angioplasty. 61/84 patients under
went follow-up angiography after 5 +/- 2 months for quantitative asses
sment of RWM changes using serial analysis with the centerline method
in 45 pts with technically suitable paired angiograms. Myocardial regi
ons were classified according to semiquantitative analysis of regional
sestamibi and FDG uptake as either normal, regions with evidence for
maintained viability but no mismatch (''mild match''), regions with a
perfusion/metabolism ''mismatch,'' or scar. RWM improved in ''mismatch
'' regions from -2.2 +/- 1.0 SD to -1.0 +/- 1.4 SD (p < 0.01) compared
to the mean of a normal reference population. In contrast, in regions
with a ''mild match'' or those classified as scar, RWM analysis revea
led no functional changes at follow-up. For the assessment of clinical
outcome, patients were divided into three groups depending on the res
ult of viability imaging. Those with predominantly scar tissue in the
target region for viability assessment (group A, n = 90), those with a
''mild match'' (B, n = 26), and group C (n = 45) consisting of patien
ts with a ''mismatch'' pattern. Subsequent treatment was not blinded t
o nuclear imaging results and revascularization was performed in 30 %
of group A (group A2), 81 % of group B, and 80 % of group C, while the
other patients were treated medically only. Cardiac events during fol
low-up were defined as cardiac death, myocardial infarction, unstable
angina with subsequent revascularization, cardiac transplantation, and
survived resuscitation without evidence for myocardial infarction. Gr
oup C demonstrated a significant reduction of cardiac events from 22 %
to 0 % following revascularization, whereas in group A coronary revas
cularization did not influence the frequency of events. Subjective ass
essment of angina pectoris and heart failure symptoms revealed more pa
tients with improvement following revascularization as compared to tho
se treated medically. Thus, combined nuclear imaging using sestamibi S
PECT and FDG PET with quantitative tracer uptake analysis allows detec
tion of absent or preserved myocardial viability in regions with reduc
ed perfusion and function with prognostic implication for regional myo
cardial functional outcome as well as for identification of patients w
ho benefit most from coronary revascularization.